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AbsTrACT
background/aims To systematically compare the 
intermodality and inter-reader agreement for two blue-
light confocal fundus autofluorescence (FAF) systems.
Methods Thirty eyes (21 patients) with a diagnosis 
of geographic atrophy (GA) were enrolled. Eyes were 
imaged using two confocal blue-light FAF devices: (1) 
Spectralis device with a 488 nm excitation wavelength 
(488-FAF); (2) EIDON device with 450 nm excitation 
wavelength and the capability for ’colour’ FAF imaging 
including both the individual red and green components 
of the emission spectrum. Furthermore, a third imaging 
modality (450-RF image) isolating and highlighting 
the red emission fluorescence component (REFC) was 
obtained and graded. Each image was graded by 
two readers to assess inter-reader variability and a 
single image for each modality was used to assess the 
intermodality variability.
results The 95% coefficient of repeatability (1.35 mm2 
for the 488-FAF-based grading, 8.13 mm2 for the 
450-FAF-based grading and 1.08 mm2 for the 450-RF-
based grading), the coefficient of variation (1.11 for 
488-FAF, 2.05 for 450-FAF, 0.92 for 450-RF) and the 
intraclass correlation coefficient (0.994 for 488-FAF, 
0.711 for 450-FAF, 0.997 for 450-RF) indicated that 
450-FAF-based and 450-RF-based grading have the 
lowest and highest inter-reader agreements, respectively. 
The GA area was larger for 488-FAF images (median 
(IQR) 2.1 mm2 (0.8–6.4 mm2)) than for 450-FAF images 
(median (IQR) 1.0 mm2 (0.3–4.3 mm2); p<0.0001). There 
was no significant difference in lesion area measurement 
between 488-FAF-based and 450-RF-based grading 
(median (IQR) 2.6 mm2 (0.8–6.8 mm2); p=1.0).
Conclusion The isolation of the REFC from the 450-
FAF images allowed for a reproducible quantification of 
GA. This assessment had good comparability with that 
obtained with 488-FAF images.
InTroduCTIon
Geographic atrophy (GA) is the non-neovascular 
form of late age-related macular degeneration 
(AMD).1 GA has an estimated prevalence of 0.8% 
in the US population 40 years of age and older and 
is still considered a serious complication of AMD 
since no approved therapy is currently available.2
In most studies and ongoing clinical trials, the 
quantification of the GA size has been performed 
using a confocal scanning laser ophthalmoscope 
(cSLO) with 488 nm blue-light fundus autofluo-
rescence (488-FAF).3–7 This 488 nm wavelength is 
thought to primarily excite lipofuscin, which domi-
nates the corresponding long-wave emission range 
between 560 and 700 nm (red spectrum).8 As loss 
of the RPE and photoreceptors in GA is associ-
ated with loss of lipofuscin, 488-FAF allows areas 
of GA to be defined as regions of well-demarcated 
decreased autofluorescence.9–11
The autofluorescence of the retina and RPE, 
however, can be excited across a broad range of wave-
lengths. Depending on the wavelength used, the quan-
tity of fluorescence and contributions to the whole 
autofluorescence signal from different fluorophores 
might vary.8 12 Recently, a new confocal 450 nm 
blue-light FAF device (450-FAF) (Eidon; CenterVue, 
Padua, Italy) has been introduced.13 A different range 
of fluorophores are thought to be excited at 450 nm 
compared with 488 nm.8 In addition to the lipo-
fuscin, the 450 nm wavelength may further excite 
other minor fluorophores, which contribute to the 
fluorescence intensity in the short-wavelength emis-
sion range (510–560 nm, green spectrum).8 Although 
this additional excitation may allow better character-
isation of these minor fluorophores,13 this may have 
consequences on the reliability of 450-FAF to detect 
and quantify GA.
In addition, this new confocal light-emitting 
diode (LED) 450 nm blue-light FAF system offers an 
important potential advantage in that the full-emis-
sion spectrum is detected on a colour sensor, 
providing so-called ‘colour FAF’ imaging. Therefore, 
the emission spectrum can be divided into long-wave 
and short-wave emission components (‘red’ and 
‘green’ emission fluorescence component, REFC 
and GEFC, respectively). As they presumably reflect 
different fluorophores, the REFC and GEFC may 
offer different capabilities for evaluating GA lesions.
The aim of this study was to systematically compare 
the intermodality and inter-reader agreement for 
488-FAF and 450-FAF images, as well as 450-red 
filtered (RF) images, in which the REFC component 
was enhanced from the 450-FAF images.
MeThods
study participants
This study is a prospective, observational, cross-sec-
tional case series. Patients with a clinical diagnosis 
of GA1 were enrolled from the medical retina clinics 
at the Doheny–UCLA Eye Centers. The study was 
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Figure 1  Representation of the algorithm used to process the images. In order to isolate the red emission fluorescence component (REFC) and 
obtain the 450-red filtered (RF) images, the colour fundus autofluorescence (FAF) image was duplicated and the two resulted images underwent the 
following process: (1) one image was first transformed in a 32-bit image and thus converted in an 8-bit greyscale image; (2) the other (duplicate) 
image subject to the ‘split channels’ function, which splits the image into the respective red and green image channels (note: no blue channel is 
present in a colour FAF image). Finally, in order to optimise the visualisation of those regions where the REFC is absent or the autofluorescence is 
mainly due to the presence of green emission fluorescence component, a ‘subtraction’ function was performed, subtracting the ‘green channel’ of the 
colour FAF image from the obtained greyscale FAF image, to yield the 450-RF FAF image.
approved by the UCLA Institutional Review Board and adhered 
to the tenets of the Declaration of Helsinki and Health Insurance 
Portability and Accountability Act. Written informed consent 
was obtained from all subjects prior to enrolment in the study.
All patients were enrolled between September 2016 and 
August 2017 and received a complete ophthalmological exam-
ination, which included the measurement of best-corrected 
visual acuity (BCVA), intraocular pressure and dilated ophthal-
moscopy. BCVA measurements were made using a Snellen chart 
and were converted to the logarithm of the minimum angle of 
resolution (logMAR), as previously described.14
To be included, patients were required to have evidence of 
GA due to AMD as determined by the managing physician (SRS) 
and defined as well-demarcated areas of depigmentation with 
increased visibility of underlying choroidal vessels on fundus-
copic examination. Moreover, in patients considered for enrol-
ment, presence of GA was further confirmed by spectral-domain 
optical coherence tomography (SD-OCT) examination, which 
revealed the concomitant appearance of RPE atrophy. Exclu-
sion criteria were (1) insufficiently clear media to allow retinal 
imaging, (2) history of any other macular or retinal disease aside 
from age-related macular degeneration, (3) extension of the area 
of atrophy beyond the field of the image and (4) evidence or 
history of neovascularisation.
Imaging
All imaging was performed following pupillary dilation. The 488 
nm FAF imaging was performed using a Spectralis (Heidelberg 
Engineering, Heidelberg, Germany) device which uses a 488 nm 
illumination wavelength and emission detection between 500 
and 700 nm. The field of view was set to 30×30° (resolution of 
768×768 pixels). Several single FAF were automatically aligned 
and averaged to maximise the signal-to-noise ratio using the 
manufacturer’s software.
The 450 nm FAF images were obtained with a confocal fundus 
imaging system (Eidon; CenterVue), which has an emission spec-
trum detection of 500 to 750 nm. The device automatically 
aligns the patient such that the optics and light path are centred 
in the pupil and an autofocus procedure is then performed to 
compensate for the eye’s spherical defect. A greyscale FAF image 
with a frame size of 60(h)×55(w) degrees and a resolution of 
3680×3288 pixels was acquired with a single exposure. The 
device also generates a ‘colour’ image (colour FAF) based on the 
detected autofluorescence wavelength. This colour FAF image 
consists of only the ‘red’ and ‘green’ channels.
SD-OCT imaging was performed using a Cirrus OCT (Carl 
Zeiss Meditec, Dublin, California, USA) with a macular cube 
512×128 scan protocol covering a 6×6 mm area centred onto 
the fovea. To be included in the analysis, a signal strength of 
at least 6 was required (as recommended by the manufacturer 
manual). Only the infrared reflectance image acquired concomi-
tantly with the OCT was used for this analysis.
Image processing—red filtered image
As the commercial Eidon FAF system does not currently auto-
matically provide an image isolating the autofluorescence 
predominantly due to the presence of REFC, additional image 
processing was performed, as illustrated in figure 1.
For each eye, the 450 nm colour FAF image was exported 
and then imported into image analysis ImageJ software  V.1.50 
(National Institutes of Health, Bethesda, Maryland, USA; avail-
able at http:// rsb. info. nih. gov/ ij/ index. html). The colour FAF 
image was duplicated and the two resultant images underwent 
two different processes.
One image was processed with the ‘split channels’ function, 
which splits the image into the respective red (R) and green (G) 
image channels (no blue channel (B) was present in the colour 
FAF image).
The second image was first transformed in a 32-bit greyscale 
image and then converted to an 8-bit greyscale image. This trans-
formation reduces information loss since after this conversion, 
the 8-bit image uses the current minimum and maximum as the 
white and black reference points, stretching or compressing 
everything in between.
Finally, in order to optimise the visualisation of those regions 
where autofluorescence is mainly due to the presence of REFC, 
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Figure 2 Schematic of the grading protocol. For each eye, all the three images for grading (488-FAF, 450-FAF and 450-RF) were registered to the 
same size and location. Then, two certified graders independently delineated the border of the geographic atrophy lesions. After grading of all the 
cases was completed, graders later met to compare level of agreement and, for each case, a single graded image was chosen after further discussion 
and open adjudication.
a ‘subtraction’ function was performed, subtracting the ‘green 
channel’ of the colour FAF image from the obtained greyscale 
FAF image, to yield the 450-RF image.
By using this approach rather than simply using the red 
channel of the colour FAF image, all those regions where the 
intensity of the REFC is 0 and/or the autofluorescence is mainly 
due to the presence of GEFC are thus masked (please see ‘Meth-
odology—online supplementary material 1’ for further details).
Image processing—green emission fluorescence component 
isolation
The image-processing algorithm to isolate and evaluate the GEFC 
within the GA has been previously described.13 In brief, the 
‘subtraction’ function is applied, subtracting the ‘red channel’ of 
the colour FAF image from the greyscale FAF image, to yield the 
image highlighting the GEFC from the 450 color-FAF image. By 
using this approach rather than simply using the green channel 
of the colour FAF image, all those regions where the GEFC is 
at least equivalent to the REFC are thus masked. Finally, the 
processed images were ‘binarised’ to identify areas exhibiting 
regions of strong GEFC signal following the subtraction feature. 
The GEFC area within the GA, which corresponded to the area 
occupied by pixels over the applied threshold, was thus auto-
matically calculated in millimetres.2 This value was used in 
order to determine whether the increased activation of short-
wave fluorophores with the 450 nm wavelength influenced the 
inter-reader and intermodality variability (online supplementary 
figure 1).
Grading protocol
The grading protocol is illustrated in figure 2.
First, all three images (488-FAF, 450-FAF and 450-RF) were 
opened in the image analysis software, ImageJ, and registered 
to the same size and location. Then, two certified Doheny 
Image Reading Center (DIRC) graders (MGN and NSA) 
independently delineated the border of the GA lesions. Only 
areas of definite decreased autofluorescence were graded, as 
previously described.15 16 Graders were masked for the image 
modality and all the images were mixed and randomly graded. 
Since both 450 nm and 488 nm excitation wavelengths are 
known to be limited in the assessment of the fovea by macular 
pigment absorption,17 infrared images from OCT scans were 
masked throughout the grading process and were unmasked 
only when foveal involvement was deemed questionable after 
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Table 1  Comparison of measurement from three imaging 
modalities
488-FAF 450-FAF 450-rF
Mean absolute inter-reader 
difference (mm2) 0.46 2.01 0.25
CR (mm2) 1.35 8.13 1.08
CV 1.11 2.05 0.92
ICC 0.994 0.711 0.997
GA area (mm2), median (IQR) 2.1 (0.8–6.4) 1.0 (0.3–4.3) 2.6 (0.8–6.8)
 CR, 95% coefficient of repeatability; CV, coefficient of variation; FAF, fundus 
autofluorescence; GA, geographic atrophy; ICC, intraclass correlation coefficient; 
450-FAF, FAF with the 450 nm wavelength excitation light; 450-RF, image obtained 
from the elaboration of the ‘colour’ 450-FAF; 488-FAF, FAF with the 488 nm 
wavelength excitation light.
grading of FAF images. To facilitate the masking, the grading 
tasks were also carried out on separate days. Grading results 
were exported as a binary mask and automatically calculated 
in millimetres2.
After grading of all the cases was completed, graders later 
met to compare level of agreement and, for each case, a single 
graded image was chosen after further discussion and open 
adjudication. In those cases in which the two graders did not 
agree on a single consensus result, the final decision was made 
by the emeritus medical director of the DIRC (SRS). This image 
obtained after adjudication was used to assess the intermodality 
variability. Furthermore, in the 488-FAF images in which the 
GA lesion measured smaller compared with the 450-RF images, 
a third grader (EB) correlated regions of discordance with the 
OCT B-scans.
statistical analysis
Statistical calculations were performed using Statistical Package 
for Social Sciences (V.20.0; SPSS).
For each imaging modality (488-FAF, 450-FAF and 450-RF), 
the intraclass correlation coefficient (ICC; two-way random, 
absolute agreement), the 95% coefficient of repeatability (CR) 
and the coefficient of variation (CV) were determined. For visu-
alisation of the level of agreement, Bland-Altman graphs were 
plotted. For each imaging modality, Spearman’s rank correlation 
coefficient (ρ) was calculated between the absolute intergrader 
differences and the GEFC area values in order to determine 
whether measurement variability increases with the activation of 
short-wave fluorophores.
Friedman's two-way analysis of variance non-parametric test 
was conducted to compare the graded GA area among the three 
imaging modalities, in order to assess the intermodality vari-
ability. Spearman’s rank correlation coefficient was calculated 
between the GEFC area values and the absolute differences 
between 450-FAF-based and 488-FAF-based grading.
The chosen level of statistical significance was p <0.05.
The sample size of the study was tested to be proper for a 
mean difference between groups of almost 10%, a power of 80% 
and type I error rate (α) of 5%.
resulTs
Thirty eyes (21 patients, 6 men) with GA were enrolled. 
Mean±SD age of the patients enrolled was 83.0±6.5 years 
(range 70–93 years). BCVA was 0.47±0.32 logMAR. Twen-
ty-one eyes were characterised by foveal sparing.
Inter-reader agreement
The level of agreement between graders is illustrated in the 
Bland-Altman plots (online supplementary figure 2) and in 
table 1. The mean absolute inter-reader difference between 
measured GA areas was 0.46, 2.01 and 0.25 mm2 for 488-FAF, 
450-FAF and 450-RF images, respectively. The CR (the value 
below which the difference between two measurements will lie 
in 95% of cases) was 1.35 mm2 for the 488-FAF-based grading, 
8.13 mm2 for the 450-FAF-based grading and 1.08 mm2 for the 
450-RF-based grading. Likewise, the CV (1.11 for 488-FAF, 
2.05 for 450-FAF, 0.92 for 450-RF) and ICC (0.994 for 
488-FAF, 0.711 for 450-FAF, 0.997 for 450-RF) indicated that 
450-FAF-based and 450-RF-based grading have the lowest and 
highest inter-reader agreements, respectively.
The GEFC area within the GA (median 0.2 mm2; IQR 0.0–1.1 
mm2) was significantly correlated with the absolute inter-reader 
difference for 450-FAF images (ρ=0.550 and p=0.002), but 
not for 488-FAF and 450-RF images (ρ=0.198 and p=0.295, 
ρ=−0.049 p=0.798, respectively).
Intermodality comparison
Median (IQR) GA graded areas were 2.1 mm2 (0.8–6.4 mm2), 
1.0 mm2 (0.3–4.3 mm2) and 2.6 mm2 (0.8–6.8 mm2) for the 
488-FAF, 450-FAF and 450-RF images, respectively (table 1, 
figure 3).
The GA area measurement was larger for 488-FAF images 
than for 450-FAF images (p<0.0001). Similarly, 450-RF-based 
measurements were significantly larger than 450-FAF-based 
measurements (p<0.0001). There was no significant differ-
ence in lesion area measurement between 488-FAF-based and 
450-RF-based grading (p=1.0).
The GEFC area values within the GA were significantly 
correlated with the absolute differences between 450-FAF-based 
and 488-FAF-based GA area grading (ρ=0.727 and p<0.0001). 
The disagreement in 450-FAF-based and 488-FAF-based GA size 
grading was not influenced by foveal involvement (p=0.306 in 
the comparison between foveal involvement and foveal sparing 
eyes).
dIsCussIon
In this prospective, cross-sectional study, we compared two 
blue-light confocal FAF systems, which differ in light source 
and wavelength for excitation (488 nm SLO and 450 nm LED). 
Overall, we observed that the increased excitation of short-wave-
length GEFC-emitting fluorophores may negatively impact the 
reliability of 450-FAF for detection and measurement of GA. 
However, the isolation of the REFC from the 450-FAF images 
allowed for an accurate and reproducible quantification of GA 
lesions.
Numerous studies have evaluated eyes with GA using 
488-FAF.18 19 Using an excitation wavelength of 488 nm and 
an emission bandwidth of 500–700 nm, GA areas exhibit very 
low to extinguished autofluorescence signal as RPE and photo-
receptor cell death is accompanied by loss of lipofuscin.10 20–22 
The latter aspect leads to a high contrast between the atrophic 
and perilesional retina with an accurate measurement of the GA 
area allowing the enlargement of these lesions to be precisely 
monitored.
Our group has recently studied the AMD-associated macular 
atrophy using a 450 nm wavelength FAF device.13 While at 
488 nm the retinal fluorescence intensity is dominated by the 
fluorescence from lipofuscin fluorophores, other minor fluo-
rophores contribute to the fluorescence when the retina is 
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Figure 3  Fundus autofluorescence images from three eyes (one for each line) affected by geographic atrophy. The 488 nm fundus autofluorescence 
(FAF) image (left) shows well-demarcated areas of definite decreased autofluorescence. These areas are not visible in the 450-FAF image (left-middle). 
The colour FAF image (right-middle) shows that in those areas of disagreement between the 488-FAF and 450-FAF, despite a reduced red emission 
autofluorescence component (REFC), the green emission autofluorescence component is still present. The image that highlights the REFC (right, 450-
RF FAF) improves the 450-FAF’s capability to detect areas of definite decreased autofluorescence due to lipofuscin reduction/absence. In the second 
line, white arrows highlight the principal region of disagreement between the two FAF modalities.
excited with the 450 nm wavelength.8 Given that these minor 
fluorophores contribute to the fluorescence intensity in the 
short-wavelength emission range (510–560 nm, green spec-
trum), we demonstrated that the bed of atrophy appears to be 
characterised by residual green-component autofluorescence 
emission signal. Moreover, complementary OCT imaging 
allowed us to define the morphological associations of these 
areas of GEFC. Specifically, we observed that high GEFC signal 
corresponded to subretinal hyper-reflective material. Compar-
ison with previous histological studies23 allowed us to specu-
late that this material, which appears to be residual drusenoid 
material, may be composed in part of advanced glycation end 
products). Therefore, using a 450 nm wavelength allows us to 
investigate minor fluorophores, which might have a prognostic 
role in AMD progression.
In the present study, we observed that 450-FAF-based lesion 
measurements were significantly smaller than 488-FAF-based 
measurements. Furthermore, we found an association between 
the intermodality disagreement and the quantity of GEFC within 
the GA area. These results thus confirmed our hypothesis that 
the increased activation of minor fluorophores may reduce the 
450 nm wavelength FAF device’s capability to detect and assess 
the GA.
Since the presence of short-wave fluorophores may influ-
ence the GA evaluation in the 450-FAF grading, we created 
an image-processing algorithm to highlight and isolate the 
REFC signal, which is thought to originate from lipofuscin 
fluorophores. This processing approach, which was facilitated 
by separation of the colour FAF image into red and green chan-
nels, allowed us to generate this third type of FAF image, which 
we termed the 450-RF image. Our analysis demonstrated a 
high level of intermodality agreement between 488-FAF and 
450-RF measurements, which appears to validate our hypoth-
esis that isolation of the REFC improves the capability of 
450-FAF imaging to assess the area of GA. In other words, 
we speculate that the presence of minor fluorophores consti-
tuting hyperreflective ‘debris’ within the bed area of the GA 
may impact GA assessment by 450-FAF images, and that image 
processing to highlight the REFC from the 450-FAF images 
facilitates a more accurate identification of regions without 
lipofuscin. An alternative hypothesis is that the RPE atrophy 
may unmask and thus increase the short-wavelength fluores-
cence from collagen in Bruch’s membrane and the choroid, 
which may confound the 450-FAF assessment and may also be 
addressed by our image processing approach.
Of note, though not statistically significant, we observed a 
trend for a slightly larger GA area measurement from 450-RF 
images compared with 488-FAF images. This aspect may be 
partially due to the fact that even though short-wave fluoro-
phores have very weak fluorescence when excited with the 488 
nm wavelength, they still contribute (although minimally) to 
the total fluorescence in 488-FAF images. In a post hoc review 
of the 488-FAF images in which the GA lesion measured 
smaller compared with the 450-RF images, we observed that 
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Figure 4  Fundus autofluorescence images from the left eye of a 75-year-old patient affected by geographic atrophy. Either 488 nm fundus 
autofluorescence (FAF) image (left) and 450-red filtered (RF) FAF image shows well-demarcated areas of definite decreased autofluorescence. In a 
post hoc review of this case, we found an area of disagreement between the two modalities (highlighted and magnified in the two FAF images), 
which was included only in the 450-RF-based grading. We observed that in the region of the macula where the grading was discordant, the putative 
atrophy did not appear as hypofluorescent on the 488-FAF image (eg, ‘grey’ appearance rather than ‘black’), and thus the grader presumably was 
not certain as to whether such regions should be included as atrophy. In this case, the area of disagreement correlated with the presence of hyper-
reflective material located within the bed of atrophy (white stars), as demonstrated in the spectral-domain optical coherence tomography scans.
in regions of the macula where the grading was discordant, 
the putative atrophy did not appear as hypofluorescent (eg, 
‘grey’ appearance rather than ‘black’), and thus the grader 
presumably was not certain as to whether such regions should 
be included as atrophy (figure 4). Previous studies have shown 
that this may be due to subretinal hyper-reflective material 
located within the bed of atrophy,24 and more recently we 
have shown that this material is composed of green-emitting 
fluorophores.13 Even for 488-FAF imaging, these green-emit-
ting fluorophores may interfere with assessment of GA-related 
hypoautofluorescence. Further studies comparing 488-FAF 
and 450-RF imaging with other image modalities (eg, OCT) 
should be performed to determine whether the isolation of 
the REFC from the 450-FAF images may provide an increased 
specificity and sensibility in quantifying GA.
The recently published ‘Classification of Atrophy Meeting’ 
consensus has recommended the use of colour fundus photog-
raphy, 488-FAF, near-infrared and OCT in clinical trials with 
GA quantification.25 26 Several studies have assessed the inter-
reader agreement of these modalities, which was reported to 
be highest for 488-FAF and OCT imaging modalities.22 Our 
results similarly showed an excellent inter-reader agreement 
in the 488-FAF-based grading. In contrast, the ICC and CV 
values were worse in the 450-FAF images. Furthermore, even 
the CR, which is known to be independent of the average 
lesion size, was worse in the 450-FAF-based measurements. 
The reduced inter-reader agreement for the 450-FAF images 
was hypothesised to be secondary to the increased activation 
of the short-wave fluorophores. Since they have a very weak 
fluorescence signal compared with lipofuscin, their excitation 
may make the GA border challenging to delineate. Strong 
evidence corroborating this hypothesis is furnished by our 
results, which showed a positive correlation between GEFC 
area within the GA and the absolute inter-reader difference 
for 450-FAF images.
Of note, the highest inter-reader agreement was observed for 
450-RF-based grading. This is most likely attributable to the 
sharper contrast at lesion boundaries in these images, as the GA 
lesion appeared to be more uniformly hypoautofluorescent in 
these 450-RF images.
Our study has some limitations that should be considered 
when assessing our findings. First, the sample size of the cohort 
is relatively small, which reduces the power of our analysis. In 
particular, we were not powered to evaluate for small differ-
ences between the 488-FAF and 450-RF assessments. Second, 
we did not enrol patients with significant media opacities. 
Since opacities may affect more the transmission of shorter 
wavelength light, our conclusions are thus limited to those eyes 
with relatively clear ocular media, which permit good-quality 
imaging. Moreover, the image processing we adopted to high-
light the REFC is novel and may have limitations. Impor-
tantly, a basic problem with any image subtraction procedure 
is that the noise level in the resulting image is higher and can 
confound the analysis.27 Thus, we are not able to quantify how 
this increased noise may have influenced our results. In addi-
tion, colour FAF imaging is still a technology in evolution, and 
the optimal processing approaches have yet to be established. 
A final limitation is that we included eyes affected by GA with 
and without foveal involvement. However, the presence of 
foveal involvement was demonstrated to not affect the inter-
modality comparison. Finally, the foveal mean fluorescence 
intensity as a function of the excitation wavelength is almost 
constant in the range of 450–500 nm.17
In summary, using 450 nm short blue-light excitation wave-
length and separate detection of both the green and red compo-
nents of the autofluorescence signal allowed an accurate and 
reproducible quantification of GA in patients with AMD. The 
images obtained by isolating the red-component autofluores-
cence emission have the highest inter-reader agreement, along 
with good comparability with 488-FAF images. Further studies 
comparing 450-RF imaging with other image modalities such as 
OCT would be of benefit. Regardless, the potential of 450-RF 
imaging to evaluate GA lesions warrants further study and may 
be of particular relevance given the many ongoing trials of 
potential therapeutics for GA.
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